Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 2,101–2,125 of 7,816 matching trials · page 85 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation
NCT06094192
High definition transcranial electrical current stimulation
Runs in: United States · 1 site
NA
other
RECRUITING 204 Boston University Charles River Campus
OTHER
2025-09-19
Psychiatric Phenotype Characterization of Individuals With FOXP1 Syndrome
NCT06211673
Semi-structured interviews; Heteroquestionnaires
Runs in: France · 1 site
NA
other
COMPLETED 25 Assistance Publique - Hôpitaux de Paris
OTHER
2025-09-19
The PredictPlusPrevent Study
NCT06351800
Predictplusprevent intervention; Psychoeducational intervention
NA
other
NOT_YET_RECRUITING 9,000 The Mediterranean Institute for the Advance of Biotechnology and Health Research
OTHER
2025-09-19
The Effect of Regular Home Use of Dual-light Antibacterial Photodynamic Therapy (aPDT) or the Use of a Powered Toothbrush in Older Individuals With Periodontitis and Mild Cognitive Impairment.
NCT07166224
Oral-B Powered toothbrush; Dual-Light aPDT Treatment - Lumoral
Runs in: Sweden · 1 site
NA
other
NOT_YET_RECRUITING 90 Blekinge Institute of Technology
OTHER
2025-09-19
Effects of Video Games and Ball Tossing on Eye Hand Coordination in Elderly With Mild Cognitive Impairment.
NCT07182396
Experimental Group; Control Group
Runs in: Pakistan · 1 site
NA
other
RECRUITING 34 Foundation University Islamabad
OTHER
2025-09-19
Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease
NCT05811442
50561 high dose; 50561 low dose; Placebo
Runs in: China · 12 sites
PHASE2
other
COMPLETED 68 Beijing Joekai Biotechnology LLC
INDUSTRY
2025-09-18
Effectiveness of a Dementia Anti-Stigma Intervention in Rural Kenya
NCT07180719
Dementia anti stigma intervention
NA
other
NOT_YET_RECRUITING 184 Africa Institute of Mental and Brain Health (AFRIMEB)
OTHER
2025-09-18
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B
NCT03787758
SAGE-718
Runs in: United States · 2 sites
PHASE1
other
COMPLETED 6 Supernus Pharmaceuticals, Inc.
INDUSTRY
2025-09-17
In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Wearables
NCT05159557
In-Home Technology System; Limited In-Home Technology
Runs in: United States · 1 site
NA
other
COMPLETED 63 University of California, Berkeley
OTHER
2025-09-17
In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Spanish Language Homes
NCT05159596
In-Home Technology System; Limited In-Home Technology
Runs in: United States · 1 site
NA
other
COMPLETED 6 University of California, Berkeley
OTHER
2025-09-17
Stress and Hypertension in Dementia Caregivers
NCT05721482
Caregiver Training
Runs in: United States · 1 site
NA
other
COMPLETED 28 Ohio State University
OTHER
2025-09-17
Advances in Neuropsychological Diagnostics
NCT05794061
Neuropsychological instruments
Runs in: Italy · 1 site
NA
other
RECRUITING 300 Istituto Auxologico Italiano
OTHER
2025-09-17
Small Steps Towards Improving Activity and Sleep Habits to Decrease the Risk of Dementia
NCT06291909
Small Steps Program; Comparator Program
Runs in: Australia · 1 site
NA
other
ACTIVE_NOT_RECRUITING 88 University of South Australia
OTHER
2025-09-17
Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease
NCT07178678
NeuroEPO; Placebo
Runs in: Canada · 1 site
PHASE2
other
NOT_YET_RECRUITING 90 University of Saskatchewan
OTHER
2025-09-17
The Effects of Chicken Extract and a Peptide Supplement for the Prevention of Cognitive Decline in Non-demented Elderly Adults
NCT04555655
Chicken extract supplement; Peptide Supplement; Placebo
Runs in: Taiwan · 3 sites
EARLY_PHASE1
other
COMPLETED 276 Brand's Suntory Asia
INDUSTRY
2025-09-16
Decision Aid for Dementia Therapies
NCT06638632
Decision aid
Runs in: United States · 1 site
NA
other
NOT_YET_RECRUITING 100 University of Colorado, Denver
OTHER
2025-09-16
Transcranial Pulse Stimulation for Alzheimer's Disease
NCT07143734
transcranial pulse stimulation (TPS); transcranial pulse stimulatio...
Runs in: Hong Kong · 1 site
PHASE2
other
RECRUITING 40 Chinese University of Hong Kong
OTHER
2025-09-16
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)
NCT04476017
SAGE-718
Runs in: United States · 4 sites
PHASE2
other
COMPLETED 18 Supernus Pharmaceuticals, Inc.
INDUSTRY
2025-09-15
Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease
NCT04482179
Active TMS; CILT; Sham TMS
Runs in: United States · 1 site
PHASE1
other
COMPLETED 23 University of Pennsylvania
OTHER
2025-09-15
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
NCT04602624
SAGE-718
Runs in: United States · 10 sites
PHASE2
other
COMPLETED 26 Supernus Pharmaceuticals, Inc.
INDUSTRY
2025-09-15
A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)
NCT05107128
SAGE-718; Placebo
Runs in: Australia; Canada; United Kingdom; United States · 49 sites
PHASE2
other
COMPLETED 189 Supernus Pharmaceuticals, Inc.
INDUSTRY
2025-09-15
Deafness and Cognition in Middle-aged Adults
NCT05149742
Cognitive and audiometry evaluation
Runs in: France · 1 site
NA
other
RECRUITING 180 Assistance Publique - Hôpitaux de Paris
OTHER
2025-09-15
28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease
NCT05358821
SAGE-718; Placebo
Runs in: Canada; United States · 14 sites
PHASE2
other
COMPLETED 69 Supernus Pharmaceuticals, Inc.
INDUSTRY
2025-09-15
The Effects of Multidomain Non-pharmacological Interventions on the Elderly With or Without Mild Cognitive Impairment
NCT05483790
the multimodal intervention
Runs in: China · 1 site
NA
other
COMPLETED 120 Huashan Hospital
OTHER
2025-09-15
A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
NCT05619692
SAGE-718; SAGE-718-matching Placebo
Runs in: Puerto Rico; United States · 39 sites
PHASE2
other
COMPLETED 174 Supernus Pharmaceuticals, Inc.
INDUSTRY
2025-09-15

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →